Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and PK of Gepotidacin Formulations
NCT02853435Phase 1Completed
- Sponsor
- GSK
- Start
- Aug 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of gepotidacin in bacterial infection (7 arms), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Time 0 Extrapolated to Infinite Time at Day 3, Area Under the Concentration-time Curve From Time 0 to Last Quantifiable Concentration at Day 3 and 8 more. Started Aug 2016; status: completed.
02
Drugs
gepotidacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02853435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02853435.